Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2023 to Q4 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
ACST
Shares outstanding
15,497,515
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ADAR1 Capital Management, LLC 9.9% -0.9% 1,534,254 +2.1% ADAR1 Capital Management GP, LLC 30 Sep 2025

Institutional Holders of Grace Therapeutics, Inc. - Common Stock, par value $0.0001 per share (ACST) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q4 0 $0 -$3,483,547 0
2024 Q3 1,159,981 $3,483,534 -$2,904,199 $3.00 11
2024 Q2 2,152,387 $6,299,610 -$18,898 $2.93 12
2024 Q1 14,468 $50,445 -$64,067 $3.42 3
2023 Q4 571,249 $1,651,217 +$57,653 $2.89 8
2023 Q3 517,561 $1,440,297 +$1,440,297 $2.78 7